Approximately 75% of EBS patients carry dominant mutations in KRT5 and KRT14—the genes encoding keratin 5 (K5) and keratin 14 (K14), respectively—that lead to disruption of the intermediate filaments of basal keratinocytes (65,66). The gene discussed is KRT14; the disease is epidermolysis bullosa simplex.